Unione Europea - italiano - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus antigeni di superficie (emoagglutinina e neuraminidasi) del ceppo a/vietnam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccini - immunizzazione attiva contro il sottotipo h5n1 del virus dell'influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Unione Europea - italiano - EMA (European Medicines Agency)

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vaccini - active immunisation against h5 subtype of influenza a virus.

Italia - italiano - Ministero della Salute

boehringer ingelheim animal health italia s.p.a - paramixovirus tipo 3, 7 diu50, virus della rinotracheite infettiva dei tacchini ceppo vc03, 0 dict50/dose, virus lentogeno della pseudopeste, ceppo ulster 2c inattivato - virus lentogeno della pseudopeste ; ceppo ulster 2c inattivato - 1 elevato alla 8 diu50; virus della rinotracheite infettiva dei tacchini ceppo vc03 - 10 elevato alla 5; 0 dict50/dose; paramixovirus tipo 3 - 1 elevato alla 6; 7 diu50, paramixovirus tipo 3 - 1 elevato alla 6; 7 diu50; virus della rinotracheite infettiva dei tacchini ceppo vc03 - 10 elevato alla 5; 0 dict50/dose; virus lentogeno della pseudopeste ; ceppo ulster 2c inattivato - 1 elevato alla 8 diu50 - turkey paramyxovirus + turkey rhinotracheitis virus

Unione Europea - italiano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pollo - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Unione Europea - italiano - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologici per aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Unione Europea - italiano - EMA (European Medicines Agency)

seqirus s.r.l.  - il virus dell'influenza degli antigeni di superficie (emoagglutinina e neuraminidasi) del ceppo: a/turkey/turkey/1/05 (h5n1)-ceppo (nibrg-23) - influenza, human; immunization; disease outbreaks - vaccini - immunizzazione attiva contro il sottotipo h5n1 del virus dell'influenza-a. questa indicazione si basa sui dati di immunogenicità di soggetti sani a partire dall'età di 18 anni in poi, a seguito di somministrazione di due dosi di vaccino contenente un/turchia/turchia/1/05 (h5n1)-ceppo. aflunov dovrebbe essere usato in conformità con le raccomandazioni ufficiali.

Italia - italiano - Ministero della Salute

green remedies spa -

Italia - italiano - Ministero della Salute

icu medical inc - sistemi di monitoraggio cardiovascolare

Unione Europea - italiano - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologici per aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Italia - italiano - Ministero della Salute

ceva salute animale s.p.a. - herpes virus vivo cellulo associato di tacchino (hvt della malattia di marek)sierotipo 3 ceppo fc 126 - herpes virus vivo cellulo associato di tacchino (hvt della malattia di marek)sierotipo 3 ceppo fc 126 - nd pfu/dose, herpes virus vivo cellulo associato di tacchino (hvt della malattia di marek)sierotipo 3 ceppo fc 126 - nd - turkey herpes virus